<--- Back to Details
First PageDocument Content
Pharmacology / Clinical research / Design of experiments / Clinical trial / Drug discovery / Nursing research / Candesartan / Angiotensin II receptor antagonist / Placebo / Chemistry / Organic chemistry / Medicine
Pharmacology
Clinical research
Design of experiments
Clinical trial
Drug discovery
Nursing research
Candesartan
Angiotensin II receptor antagonist
Placebo
Chemistry
Organic chemistry
Medicine

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 176,39 KB

Share Document on Facebook

Similar Documents

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

DocID: 1voSH - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

DocID: 1vnKo - View Document

Scientific Program conferenceseries.com 3rd International Conference and Expo on Drug Discovery & Designing

DocID: 1vngF - View Document

5th CDDD Meeting COMPUTATIONALLY DRIVEN DRUG DISCOVERY November 16-17, 2017 | IFOM, Milan - Italy

DocID: 1vkVj - View Document